{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:40:30Z","timestamp":1761946830222,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/01\/CDE\/08\/07)"],"award-info":[{"award-number":["BT\/01\/CDE\/08\/07)"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10557-019-06890-0","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T08:03:56Z","timestamp":1563782636000},"page":"385-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis"],"prefix":"10.1007","volume":"33","author":[{"given":"Lakshmi Narasimha","family":"Thota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiruvelselvan","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2928-1726","authenticated-orcid":false,"given":"Lakshmi","family":"Mundkur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"issue":"5","key":"6890_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.ATV.0000067937.93716.DB","volume":"23","author":"GN Fredrikson","year":"2003","unstructured":"Fredrikson GN, Soderberg I, Lindholm M, Dimayuga P, Chyu KY, Shah PK, et al. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol. 2003;23(5):879\u201384.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"6890_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nm876","volume":"9","author":"CJ Binder","year":"2003","unstructured":"Binder CJ, Horkko S, Dewan A, Chang MK, Kieu EP, Goodyear CS, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med. 2003;9(6):736\u201343.","journal-title":"Nat Med"},{"issue":"6","key":"6890_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.vaccine.2011.12.043","volume":"30","author":"L Jun","year":"2012","unstructured":"Jun L, Jie L, Dongping Y, Xin Y, Taiming L, Rongyue C, et al. Effects of nasal immunization of multi-target preventive vaccines on atherosclerosis. Vaccine. 2012;30(6):1029\u201337.","journal-title":"Vaccine."},{"key":"6890_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev.immunol.22.012703.104644","volume":"22","author":"G Wick","year":"2004","unstructured":"Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol. 2004;22:361\u2013403.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"6890_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1365-2796.2008.01945.x","volume":"263","author":"J Nilsson","year":"2008","unstructured":"Nilsson J, Hansson GK. Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med. 2008;263(5):464\u201378.","journal-title":"J Intern Med"},{"issue":"8","key":"6890_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nri.2016.63","volume":"16","author":"CJ Binder","year":"2016","unstructured":"Binder CJ, Papac-Milicevic N, Witztum JL. Innate sensing of oxidation-specific epitopes in health and disease. Nat Rev Immunol. 2016;16(8):485\u201397.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"6890_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","volume":"108","author":"YI Miller","year":"2011","unstructured":"Miller YI, Choi SH, Wiesner P, Fang L, Harkewicz R, Hartvigsen K, et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res. 2011;108(2):235\u201348.","journal-title":"Circ Res"},{"issue":"4","key":"6890_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4(4):330\u20136.","journal-title":"Nat Immunol"},{"issue":"6","key":"6890_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","volume":"38","author":"P Libby","year":"2013","unstructured":"Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity. 2013;38(6):1092\u2013104.","journal-title":"Immunity."},{"issue":"3","key":"6890_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2796.2009.02150.x","volume":"266","author":"J Nilsson","year":"2009","unstructured":"Nilsson J, Fredrikson GN, Bjorkbacka H, Chyu KY, Shah PK. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease. J Intern Med. 2009;266(3):221\u201331.","journal-title":"J Intern Med"},{"issue":"6","key":"6890_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jacc.2007.04.054","volume":"50","author":"CJ Binder","year":"2007","unstructured":"Binder CJ, Hartvigsen K, Witztum JL. Promise of immune modulation to inhibit atherogenesis. J Am Coll Cardiol. 2007;50(6):547\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"6890_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","volume":"27","author":"A Mor","year":"2007","unstructured":"Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, et al. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(4):893\u2013900.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"6890_CR13","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/01.CIR.0000089083.61317.A1","volume":"108","author":"Z Mallat","year":"2003","unstructured":"Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F, et al. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation. 2003;108(10):1232\u20137.","journal-title":"Circulation."},{"issue":"3","key":"6890_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/ATVBAHA.111.242800","volume":"32","author":"O Herbin","year":"2012","unstructured":"Herbin O, Ait-Oufella H, Yu W, Fredrikson GN, Aubier B, Perez N, et al. Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2012;32(3):605\u201312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"6890_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2796.2010.02311.x","volume":"269","author":"M Wigren","year":"2011","unstructured":"Wigren M, Kolbus D, Duner P, Ljungcrantz I, Soderberg I, Bjorkbacka H, et al. Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. J Intern Med. 2011;269(5):546\u201356.","journal-title":"J Intern Med"},{"issue":"5","key":"6890_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.imbio.2011.06.006","volume":"217","author":"R Klingenberg","year":"2012","unstructured":"Klingenberg R, Ketelhuth DF, Strodthoff D, Gregori S, Hansson GK. Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe(\u2212)\/(\u2212) mice. Immunobiology. 2012;217(5):540\u20137.","journal-title":"Immunobiology."},{"issue":"1","key":"6890_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.atherosclerosis.2012.07.021","volume":"225","author":"X Lu","year":"2012","unstructured":"Lu X, Xia M, Endresz V, Faludi I, Szabo A, Gonczol E, et al. Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her) J mice. Atherosclerosis. 2012;225(1):56\u201368.","journal-title":"Atherosclerosis."},{"issue":"2","key":"6890_CR18","doi-asserted-by":"publisher","first-page":"e30780","DOI":"10.1371\/journal.pone.0030780","volume":"7","author":"KY Chyu","year":"2012","unstructured":"Chyu KY, Zhao X, Dimayuga PC, Zhou J, Li X, Yano J, et al. CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide. PLoS One. 2012;7(2):e30780.","journal-title":"PLoS One"},{"key":"6890_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fimmu.2013.00493","volume":"4","author":"K Tse","year":"2013","unstructured":"Tse K, Gonen A, Sidney J, Ouyang H, Witztum JL, Sette A, et al. Atheroprotective vaccination with MHC-II restricted peptides from ApoB-100. Front Immunol. 2013;4:493.","journal-title":"Front Immunol"},{"issue":"5","key":"6890_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1084\/jem.20092243","volume":"207","author":"A Hermansson","year":"2010","unstructured":"Hermansson A, Ketelhuth DF, Strodthoff D, Wurm M, Hansson EM, Nicoletti A, et al. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med. 2010;207(5):1081\u201393.","journal-title":"J Exp Med"},{"issue":"3","key":"6890_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/cei.12726","volume":"183","author":"Y Zhong","year":"2016","unstructured":"Zhong Y, Tang H, Wang X, Zeng Q, Liu Y, Zhao XI, et al. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis. Clin Exp Immunol. 2016;183(3):452\u201368.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"6890_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.intimp.2012.03.008","volume":"13","author":"J Long","year":"2012","unstructured":"Long J, Lin J, Yang X, Yuan D, Wu J, Li T, et al. Nasal immunization with different forms of heat shock protein-65 reduced high-cholesterol-diet-driven rabbit atherosclerosis. Int Immunopharmacol. 2012;13(1):82\u20137.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"6890_CR23","doi-asserted-by":"publisher","first-page":"e58364","DOI":"10.1371\/journal.pone.0058364","volume":"8","author":"L Mundkur","year":"2013","unstructured":"Mundkur L, Mukhopadhyay R, Samson S, Varma M, Kale D, Chen D, et al. Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)\/J mice. PLoS One. 2013;8(3):e58364.","journal-title":"PLoS One"},{"issue":"2","key":"6890_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ijcard.2014.06.001","volume":"175","author":"L Mundkur","year":"2014","unstructured":"Mundkur L, Ponnusamy T, Philip S, Rao LN, Biradar S, Deshpande V, et al. Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice. Int J Cardiol. 2014;175(2):340\u201351.","journal-title":"Int J Cardiol"},{"issue":"1","key":"6890_CR25","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1038\/s41598-017-04183-w","volume":"7","author":"LN Thota","year":"2017","unstructured":"Thota LN, Ponnusamy T, Philip S, Lu X, Mundkur L. Immune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apobtm2Sgy\/Ldlrtm1Her\/J mice. Sci Rep. 2017;7(1):3997.","journal-title":"Sci Rep"},{"issue":"11","key":"6890_CR26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nsb1194-802","volume":"1","author":"MJ Sutcliffe","year":"1994","unstructured":"Sutcliffe MJ, Jaseja M, Hyde EI, Lu X, Williams JA. Three-dimensional structure of the RGD-containing neurotoxin homologue dendroaspin. Nat Struct Mol Biol. 1994;1(11):802\u20137.","journal-title":"Nat Struct Mol Biol"},{"issue":"15","key":"6890_CR27","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/j.vaccine.2006.01.002","volume":"24","author":"PU Kumar","year":"2006","unstructured":"Kumar PU, Kumar BD, Annapurna VV, Krishna TP, Kalyanasundaram S, Suresh P, et al. Nonclinical toxicology study of recombinant-plasmid DNA anti-rabies vaccines. Vaccine. 2006;24(15):2790\u20138.","journal-title":"Vaccine."},{"issue":"8","key":"6890_CR28","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.4049\/jimmunol.172.8.4676","volume":"172","author":"N Misra","year":"2004","unstructured":"Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol. 2004;172(8):4676\u201380.","journal-title":"J Immunol"},{"issue":"6029","key":"6890_CR29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1202947","volume":"332","author":"OS Qureshi","year":"2011","unstructured":"Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science. 2011;332(6029):600\u20133.","journal-title":"Science."},{"issue":"23","key":"6890_CR30","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on A. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"6890_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1471-4906(02)02331-1","volume":"23","author":"DR Greaves","year":"2002","unstructured":"Greaves DR, Channon KM. Inflammation and immune responses in atherosclerosis. Trends Immunol. 2002;23(11):535\u201341.","journal-title":"Trends Immunol"},{"key":"6890_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ebiom.2016.06.039","volume":"9","author":"J Nilsson","year":"2016","unstructured":"Nilsson J. Can antibodies protect us against cardiovascular disease? EBioMedicine. 2016;9:29\u201330.","journal-title":"EBioMedicine."},{"key":"6890_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fimmu.2016.00127","volume":"7","author":"TL Rothstein","year":"2016","unstructured":"Rothstein TL. Natural antibodies as rheostats for susceptibility to chronic diseases in the aged. Front Immunol. 2016;7:127.","journal-title":"Front Immunol"},{"issue":"1","key":"6890_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2005.11.033","volume":"189","author":"JR Faria-Neto","year":"2006","unstructured":"Faria-Neto JR, Chyu KY, Li X, Dimayuga PC, Ferreira C, Yano J, et al. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis. 2006;189(1):83\u201390.","journal-title":"Atherosclerosis."},{"issue":"7","key":"6890_CR35","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1194\/jlr.R500005-JLR200","volume":"46","author":"CJ Binder","year":"2005","unstructured":"Binder CJ, Shaw PX, Chang MK, Boullier A, Hartvigsen K, Horkko S, et al. The role of natural antibodies in atherogenesis. J Lipid Res. 2005;46(7):1353\u201363.","journal-title":"J Lipid Res"},{"issue":"4","key":"6890_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00281-004-0185-z","volume":"26","author":"CJ Binder","year":"2005","unstructured":"Binder CJ, Silverman GJ. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol. 2005;26(4):385\u2013404.","journal-title":"Springer Semin Immunopathol"},{"issue":"12","key":"6890_CR37","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1172\/JCI8472","volume":"105","author":"PX Shaw","year":"2000","unstructured":"Shaw PX, Horkko S, Chang MK, Curtiss LK, Palinski W, Silverman GJ, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest. 2000;105(12):1731\u201340.","journal-title":"J Clin Invest"},{"issue":"1","key":"6890_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0021-9150(98)00015-X","volume":"138","author":"J George","year":"1998","unstructured":"George J, Afek A, Gilburd B, Levkovitz H, Shaish A, Goldberg I, et al. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis. 1998;138(1):147\u201352.","journal-title":"Atherosclerosis."},{"issue":"11","key":"6890_CR39","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1084\/jem.20031763","volume":"200","author":"MK Chang","year":"2004","unstructured":"Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, et al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med. 2004;200(11):1359\u201370.","journal-title":"J Exp Med"},{"issue":"7709","key":"6890_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","volume":"558","author":"X Que","year":"2018","unstructured":"Que X, Hung MY, Yeang C, Gonen A, Prohaska TA, Sun X, et al. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature. 2018;558(7709):301\u20136.","journal-title":"Nature."},{"issue":"3","key":"6890_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1179\/1351000213Y.0000000046","volume":"18","author":"G Murdaca","year":"2013","unstructured":"Murdaca G, Spano F, Cagnati P, Puppo F. Free radicals and endothelial dysfunction: potential positive effects of TNF-alpha inhibitors. Redox Rep. 2013;18(3):95\u20139.","journal-title":"Redox Rep"},{"issue":"4","key":"6890_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jcmg.2014.06.021","volume":"8","author":"J Lehrer-Graiwer","year":"2015","unstructured":"Lehrer-Graiwer J, Singh P, Abdelbaky A, Vucic E, Korsgren M, Baruch A, et al. FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity. J Am Coll Cardiol Img. 2015;8(4):493\u20134.","journal-title":"J Am Coll Cardiol Img"},{"issue":"24","key":"6890_CR43","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.jacc.2007.07.081","volume":"50","author":"A Schiopu","year":"2007","unstructured":"Schiopu A, Frendeus B, Jansson B, Soderberg I, Ljungcrantz I, Araya Z, et al. Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(\u2212\/\u2212)\/low-density lipoprotein receptor(\u2212\/\u2212) mice. J Am Coll Cardiol. 2007;50(24):2313\u20138.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-019-06890-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-019-06890-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-019-06890-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T23:32:30Z","timestamp":1595287950000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-019-06890-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["6890"],"URL":"https:\/\/doi.org\/10.1007\/s10557-019-06890-0","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[2019,7,22]]},"assertion":[{"value":"22 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Animal studies were performed and followed according to the CPCSEA guidelines and institute animal ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}